Howe & Rusling Inc Lantheus Holdings, Inc. Transaction History

Howe & Rusling Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$55.54 - $72.65 $1,221 - $1,598	-22 Reduced 22.45%	76 $5,000
Q1 2022 May 10, 2022	SELL	$24.28 - $56.64 $2,525 - $5,890	-104 Reduced 51.49%	98 $5,000
Q4 2021 Feb 14, 2022	BUY	$22.54 - $30.44 $766 - $1,034	34 Added 20.24%	202 $6,000
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $751 - $886	31 Added 22.63%	168 $4,000
Q1 2021 May 13, 2021	BUY	$13.77 - $21.66 $1,886 - $2,967	137 New	137 $3,000

532

68.9M

679K

414K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.31B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.